The Reliability and Validity of the Ankylosing Spondylitis Performance Index (ASPI) in Enthesitis-Related Arthritis

Launched by HACETTEPE UNIVERSITY · Apr 20, 2024

Keywords

ClinConnect Summary

This clinical trial is studying the Ankylosing Spondylitis Performance Index (ASPI), which is a tool used to measure how well children and teenagers with Enthesitis-Related Arthritis (ERA) can function physically. The goal of the study is to see how reliable and valid this tool is, meaning they want to ensure that it consistently provides accurate results when used to assess patients. This research is important because it can help doctors better understand how ERA affects young patients and improve their care.

To participate in this study, children and teens aged 7 to 18 who have been diagnosed with Enthesitis-Related Arthritis can volunteer. However, those with serious heart, lung, liver, or kidney diseases, neurological disorders, or significant mental health issues that could affect their involvement won’t be eligible. Participants can expect to work with researchers who will assess their physical abilities using the ASPI and help contribute to better treatment options for others with this condition. This trial is currently recruiting participants, and everyone is welcome to join regardless of gender.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Being diagnosed with Enthesitis-Related Arthritis (ERA) according to The International League of Associations for Rheumatology (ILAR) classification
• • Being between the ages of 7-18
• • Volunteering to participate in research
• Exclusion Criteria:
• • Advanced heart/lung/liver/kidney disease, neurological disease and malignancies
• • Having undergone major orthopedic surgery
• • The presence of moderate to severe mental problems that will negatively affect participation
• • Not volunteering to participate in the study